A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

Abstraction Design will debut this upcoming season at Sustainability Night — showcasing a blend of sustainable fashion and couture.

Sharon AI, Inc ("Sharon AI") a High-Performance Computing business focused on Artificial Intelligence, Cloud GPU Compute Infrastructure and Cloud Storage, announces that it has expanded its GPU fleet ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

Conference call today at 11:00 a.m. ETLAWRENCEVILLE, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage ...

Thursday, 7 November at 6 pm, Vytautas Kasiulis Museum of Art of the LNMA opens a retrospective exhibition The Worlds of Jurgis Miksevicius. It is the first in Lithuania comprehensive presentation of ...

ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") , an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on Friday, November 15, 2024, ...

Good morning, and welcome to Y-mAbs Therapeutics Inc. Third Quarter Conference Call for 2024. At this time, all participants are in a listen-only mode. Instruction for the question-and-answer session ...

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

The Campus Beautification Committee (CBC) hosted its first ever Art Rising Through (ART) Tank on Thursday, Oct. 24 in the ...